Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Collins

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Transplantation Proceedings|December 1, 1987
Graft failures after T cell depleted marrow transplants for leukemia: clinical and in vitro characteristicsN A Kernan, C Bordignon, C A Keever, et al.
Blood|August 15, 1995
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host diseaseS Mackinnon, E B Papadopoulos, M H Carabasi, et al.
Blood|February 3, 1998
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host diseaseE B Papadopoulos, M H Carabasi, H Castro-Malaspina, et al.
Bone Marrow Transplantation|January 12, 2010
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCTM-A Perales, R Jenq, J D Goldberg, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Transplantation Proceedings|December 1, 1987
Graft failures after T cell depleted marrow transplants for leukemia: clinical and in vitro characteristicsN A Kernan, C Bordignon, C A Keever, et al.
Blood|August 15, 1995
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host diseaseS Mackinnon, E B Papadopoulos, M H Carabasi, et al.
Blood|February 3, 1998
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host diseaseE B Papadopoulos, M H Carabasi, H Castro-Malaspina, et al.
Bone Marrow Transplantation|January 12, 2010
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCTM-A Perales, R Jenq, J D Goldberg, et al.
Pageof 4